Under The Radar Media

‘Accidental’ contamination of vaccine with live avian flu virus virtually impossible

Posted in Cover Up, False Flag Terrorism, Uncategorized by maasanova on March 6, 2009

 

Download this interview by former Marine Corps sniper on the subject of staged bio-terrorism and bio-weapons

 

Paul Joseph Watson
Prison Planet.com

Czech Papers Question Whether Contaminated Baxter Vaccine Was ‘Attempt to Provoke Pandemic’

Czech newspapers are questioning if the shocking discovery of vaccines contaminated with the deadly avian flu virus which were distributed to 18 countries by the American company Baxter were part of a conspiracy to provoke a pandemic.

The claim holds weight because, according to the very laboratory protocols that are routine for vaccine makers, mixing a live virus biological weapon with vaccine material by accident is virtually impossible.

“The company that released contaminated flu virus material from a plant in Austria confirmed Friday that the experimental product contained live H5N1 avian flu viruses,” reports the Canadian Press.

Baxter flu vaccines contaminated with H5N1 – otherwise known as the human form of avian flu, one of the most deadly biological weapons on earth with a 60% kill rate – were received by labs in the Czech Republic, Germany, and Slovenia.

Initially, Baxter attempted to stonewall questions by invoking “trade secrets” and refused to reveal how the vaccines were contaminated with H5N1. After increased pressure they then claimed that pure H5N1 batches were sent by accident. This was seemingly an attempt to quickly change the story and hide the fact that the accidental contamination of a vaccine with a deadly biological agent like avian flu is virtually impossible and the only way it could have happened was by wilful gross criminal negligence.

According to a compiled translation from Czech newspaper stories, the media over there is asking tough questions about whether the contamination was part of a deliberate attempt to start a pandemic.

“Was this just a criminal negligence or it was an attempt to provoke pandemia using vaccination against flu to spread the disease – as happened with the anti-B hepatitis vaccination with vaccines containing the HIV virus in US? – and then cash for the vaccines against H5N1 which Baxter develops? How could on Earth a virus as H5N1 come to the ordinary flu vaccines? Don’t they follow even basic precautions in the american pharma companies?” states the translation.

The fact that Baxter mixed the deadly H5N1 virus with a mix of H3N2 seasonal flu viruses is the smoking gun. The H5N1 virus on its own has killed hundreds of people, but it is less airborne and more restricted in the ease with which it can spread. However, when combined with seasonal flu viruses, which as everyone knows are super-airborne and easily spread, the effect is a potent, super-airbone, super deadly biological weapon.

As the Canadian Press article explains, “While H5N1 doesn’t easily infect people, H3N2 viruses do. If someone exposed to a mixture of the two had been simultaneously infected with both strains, he or she could have served as an incubator for a hybrid virus able to transmit easily to and among people.”

There can be little doubt therefore that this was a deliberate attempt to weaponize the H5N1 virus to its most potent extreme and distribute it via conventional flu vaccines to the population who would then infect others to a devastating degree as the disease went airborne.

The Canadian Press article states, “That mixing process, called reassortment, is one of two ways pandemic viruses are created,” but then claims that there is no evidence that this is what Baxter were doing, despite there being no clear explanation as to why Baxter has samples of the live avian flu virus on its premises in the first place.

However, to reiterate, the key aspect of this story is that it is virtually impossible for live avian flu virus to find its way into a vaccine by “accident”.

As health expert Mike Adams points out, “The shocking answer is that this couldn’t have been an accident. Why? Because Baxter International adheres to something called BSL3 (Biosafety Level 3) – a set of laboratory safety protocols that prevent the cross-contamination of materials.”

As explained on Wikipedia (http://en.wikipedia.org/wiki/Biosaf…):

“Laboratory personnel have specific training in handling pathogenic and potentially lethal agents, and are supervised by competent scientists who are experienced in working with these agents. This is considered a neutral or warm zone. All procedures involving the manipulation of infectious materials are conducted within biological safety cabinets or other physical containment devices, or by personnel wearing appropriate personal protective clothing and equipment. The laboratory has special engineering and design features.”

Under the BSL3 code of conduct, it is impossible for live avian flu viruses to contaminate production vaccine materials that are shipped out to vendors around the world.

This leaves only two possibilities that explain these events:

Possibility #1: Baxter isn’t following BSL3 safety guidelines or is so sloppy in following them that it can make monumental mistakes that threaten the safety of the entire human race. And if that’s the case, then why are we injecting our children with vaccines made from Baxter’s materials?

Possibility #2: A rogue employee (or an evil plot from the top management) is present at Baxter, whereby live avian flu viruses were intentionally placed into the vaccine materials in the hope that such materials might be injected into humans and set off a global bird flu pandemic.

Spreading bird flu would create an instantaneous surge of demand for bird flu vaccines. The profits that vaccine companies such as Baxter International could reap out of such a panic are astronomical.

In addition, as we have previously reported, those that have a stake in the Tamiflu vaccine include top globalists and BIlderberg members like George Shultz, Lodewijk J.R. de Vink and former Secretary of Defense Donald Rumsfeld.

Authorities in both Europe and the U.S. have openly detailed plans for martial law, quarantine and internment should a bird flu pandemic occur.

The other motivation, as we have exhaustively documented on this website for years, is the fact that elites throughout history have openly stated that they want to see a world population reduction of around 80 per cent. Shocking stories like this take the plausibility of that narrative out of the realms of conspiracy theory and into the dangerous reality of conspiracy fact.

“Baxter is acting a whole lot like a biological terrorism organization these days, sending deadly viral samples around the world. If you mail an envelope full of anthrax to your Senator, you get arrested as a terrorist. So why is Baxter — which mailed samples of a far more deadly viral strain to labs around the world — getting away with saying, essentially, “Oops?”, Adams concludes.

This is not the first time that vaccine companies have been caught distributing vaccines contaminated with deadly viruses.

In 2006 it was revealed that Bayer Corporation had discovered that their injection drug, which was used by hemophiliacs, was contaminated with the HIV virus. Internal documents prove that after they positively knew that the drug was contaminated, they took it off the U.S. market only to dump it on the European, Asian and Latin American markets, knowingly exposing thousands, most of them children, to the live HIV virus. Government officials in France went to prison for allowing the drug to be distributed. The documents show that the FDA colluded with Bayer to cover-up the scandal and allowed the deadly drug to be distributed globally. No Bayer executives ever faced arrest or prosecution in the United States.

Research related articles:

 

Discussion: Live avian flu  placed in baxter vaccine materials sent to 18 countries     

Vaccines as Biological Weapons? Live Avian Flu Virus Placed in Baxter Vaccine Materials Sent to 18 Countries

The Pentagon’s alarming project: Avian Flu Biowar Vaccine

URGENT WARNING: H5N1 DNA in Flu Vaccine

Pre-9/11 Warning of staged terror attacks/pandemic using bio-weapons  (download mp3)

Universal Vaccine for the Flu? Look No Further Than Vitamin C and Zinc

Scientists close in on ‘universal’ vaccine for flu: study

The super vaccine that protects you from all types of flu for LIFE

Novartis recalls vaccines in contamination scare

Mystery virus hits 15 million PCs around the world

Smokers should get pneumonia vaccine: U.S. advisers

The Alex Jones Show – L I V E – March 5 – The Baxter Bird Flu Scandal

Vaccine Court: Autism Debate Continues

Why Do 160,000 Cats Each Year in the USA Develop Terminal Cancer at Their Vaccine Injection Sites

Advertisements

3 Responses

Subscribe to comments with RSS.

  1. asdf02 said, on March 12, 2009 at 1:00 am

    Hello everyone. I just commented on the story regarding Baxter’s “accidental” mix-up of H5N1 on the site Fierce Vaccines (found via Google News), and my comments were deleted and closed within approximately 40 minutes. There is obviously something criminal and HIGH LEVEL going on here with Baxter. I will include both the contact information of their executives as well as my own commentary regarding what I believe to be the public exposure of a vast international biological weapons program, or if you prefer, an international corporate criminal syndicate which intends to release biological weapons upon the world population.

    BAXTER EXECUTIVES:

    You initially claimed “trade secrets” regarding the vaccine contamination. Could you explain why Baxter initially attempted to cover this up?

    ===============================
    Amundson, Joy Ms. Joy A. Amundson is Baxter International Inc.’s Corporate Vice President — President, BioScience, having served in that capacity since August 2004. Prior to joining Baxter in August 2004, Ms. Amundson was a principal of Amundson Partners, Inc., a healthcare-consulting firm, from 2001. From 1995 to 2001, she served as a Senior Vice President of Abbott Laboratories.

    Joy A Amundson
    3800 N Lk Shore Dr #6A
    Chicago, IL 60613
    (312) 281-1508

    Despite popular media claims to the contrary, coinfection of H5N1 and H3N2 would _not_ produce simple reassortment. It would produce complex in vivo recombination of many competing strains in the infected host. Does Baxter agree with this assessment?

    ===============================
    Arduini, Peter Mr. Peter J. Arduini is Baxter International Inc.’s Corporate Vice President — President, Medication Delivery. Prior to joining Baxter in March 2005, Mr. Arduini spent 15 years at GE Healthcare in a variety of management roles for domestic and global businesses, the most recent of which was global general manager of GE Healthcare’s computerized axial tomography scan (CT) and functional imaging business.

    Peter J Arduini
    1059 Warrington Rd
    Deerfield, IL 60015
    (847) 444-0056

    Furthermore the complex coinfection of H5N1 and H3N2 in a human would produce natural selection pressure for maximum virulence. Does Baxter dispute this claim? If so, why? If not, please explain why on earth would Baxter attempt to cover up an incident which may well have been lethal to 99% of humanity?

    ===============================
    Baughman, Michael Mr. Michael J. Baughman is Baxter International Inc.’s Corporate Vice President and Controller, having served in that capacity since May 2006. Mr. Baughman joined Baxter in 2003 as Vice President of Corporate Audit and was appointed Controller in March 2005. Before joining Baxter, Mr. Baughman spent 16 years at PricewaterhouseCoopers LLP, in roles of increasing responsibility, which included audit partner and partner in the firm’s mergers and acquisitions practice.

    Michael J Baughman
    779 Parker Ct
    Geneva, IL 60134
    (630) 208-8215

    The book “Evolutionary Dynamics” suggest that viral coinfection selects for both maximum virulence and infectivity. Does Baxter dispute these mathematics? Considering this danger is well known among virologists, can Baxter immediately explain the precise sequence of events, including dates, times, and people involved, which led to contamination in over 16 labs in three seperate countries in Europe with coinfected H5N1 and H3N2 material?

    ===============================
    Gatling, James Mr. James Michael Gatling is Corporate Vice President — Manufacturing of Baxter International Inc. having served in that capacity since December 1996. Mr. Gatling is also responsible for the environment, health and safety function.

    James Gatling
    3704 Lindsay Ln
    Crystal Lake, IL 60014
    (815) 356-6180

    Is Baxter prepared to cooperate with all relevent authorities in the multiple countries to publically release the genetic sequences of the contaminated material? Furthermore, what Clade was Baxter’s H5N1 vaccine from? Clade 1? Clade 2? Clade 3? Other? Is part of the reason Baxter is so eager to destroy the existing vaccine material that executives are concerned the world will find out their ‘custom’ H5N1 does not resemble the strains circulating in waterfowl?

    ===============================
    Gavin, James James R. Gavin III, M.D., Ph.D. has served as a Director of Baxter since 2003. Since September 2007, Dr. Gavin has been Chief Executive Officer and Chief Medical Officer of Healing Our Village, Inc., a corporation that specializes in targeted advocacy, training, education, disease management and outreach for health care professionals and minority communities. From March 2005 to September 2007, Dr. Gavin served as Executive Vice President for Clinical Affairs at Healing Our Village. Dr. Gavin has served as Clinical Professor of Medicine and Senior Advisor of Health Affairs at Emory University since January 2005. From January 2006 to July 2007, Dr. Gavin served as President and CEO of MicroIslet, Inc., a biotechnology company focused on transplantation therapy for insulin treated diabetics. From July 2002 to January 2005, Dr. Gavin was President of the Morehouse School of Medicine and from 1991 to July 2002 he was Senior Science Officer at Howard Hughes Medical Institute, a nonprofit medical research organization. From 1987 to 1991, he was at the University of Oklahoma Health Sciences Center as a Professor and as Chief of the Diabetes Section and Acting Chief of the Section on Endocrinology, Metabolism and Hypertension. Dr. Gavin also serves as a director of Amylin Pharmaceuticals, Inc. and Nuvelo Inc.

    James R Gavin
    440 Beverly Pl
    Lake Forest, IL 60045
    Phone Unpublished

    Can Baxter please disclose all financial and social connections it has with the incoming Obama administration (as Baxter and its executives are based near Chicago) and whether Baxter stood to benefit financially from the outbreak of a pandemic through a contaminated season influenza vaccine in late 2009? Does Treasury Sec Geithner hold shares in Baxter? If so, how many shares?

    ===============================
    Greisch, John Mr. John J. Greisch is Baxter International Inc.’s Corporate Vice President — President, International, having served in that capacity since May 2006. From June 2004 to May 2006, he served as Corporate Vice President and Chief Financial Officer and from January to June 2004, he was Corporate Vice President — President, BioScience. Prior to that, Mr. Greisch served as Vice President of Finance and Strategy for BioScience from May 2003 to January 2004 and as Vice President of Finance for Renal from March 2002 until April 2003. Prior to joining Baxter, he was President and Chief Executive Officer of FleetPride Corporation, a distribution company, from 1998 until 2001.

    John Greisch
    2636 Chesapeake Ln
    Northbrook, IL 60062
    (847) 480-0852

    John Greisch
    1310 Wildwood Ln
    Northbrook, IL 60062
    (847) 480-0852

    Baxter Director Gail Fosler has profoundly disturbing connections to powerful rganizations including the Council on Foreign Relations, high-level Chinese CCP leadership, and the Federal Reserve Bank of New York. The question is simple: Is Baxter involved in biological weapons programs? Are any of these programs ‘international’ in scope? If so , who is providing the funding? What is the nature and intent of these programs? Are any of these programs part of the so-called ‘black budget’? That is , is Baxter involed in any “Special Access Programs” , as defined by Congress? Are any of these ‘waived’ “Special Access Programs”? Are any of these ‘unacknowledged’ ‘waived’ Special Access Programs (also known as ‘black programs’)?

    ===============================
    Hellman, Peter Peter S. Hellman has served as a Director of Baxter since March 2005. Mr. Hellman served as President and Chief Financial and Administrative Officer of Nordson Corporation, a manufacturer of systems that apply adhesives, sealants and coatings during manufacturing operations, from March 2004 until his retirement in January 2008. From February 2000 to March 2004, Mr. Hellman served as Executive Vice President and Chief Financial and Administrative Officer of Nordson Corporation. From 1989 to 1999, Mr. Hellman held various positions with TRW Inc., the most recent of which were President and Chief Operating Officer. Mr. Hellman also serves as a director of Qwest Communications International Inc. and Owens-Illinois, Inc.

    Peter Hellman
    630 W Oakdale Ave #2E
    Chicago, IL 60657
    (773) 857-5227

    Can Baxter explain exactly how a Level 3 biological warfare pathogen found its way into H3N2 material, regardless whether or not this experimental vaccine material was ‘intended’ for eventual use in humans or not. Is the contaminated H5N1 strain genetically engineered? If so, by whom? Does the NS protein in Baxter’s H5N1 material contain polymorphisms which suppress human interferon production? Was Baxter’s H5N1a full set of influenza genes? Or was it just the hemaglutanin and neuraminidase? Did Baxter’s H5N1 contain a poly-basic cleavage site on the Hemaglutanin surface protein? Why were the samples of experimental vaccine material not irradiated?

    ===============================
    Lichtenstein, Susan Ms. Susan R. Lichtenstein is Corporate Vice President and General Counsel of Baxter International Inc. Prior to joining Baxter in April 2005, Ms. Lichtenstein was a partner with McDermott Will & Emery. She joined the law firm after having served as General Counsel to the Governor of Illinois from 2003 to 2004. Ms. Lichtenstein served as Senior Vice President, General Counsel and Corporate Secretary for Tellabs, Inc. from 2000 to 2002. From 1994 to 2000, Ms. Lichtenstein held several positions with Ameritech Corporation, including Senior Vice President, General Counsel and Corporate Secretary from 1999 to 2000.

    Susan Lichtenstein
    1560 N Sandburg Ter
    Chicago, IL 60610
    Phone Unpublished

    Are Baxter exectutives prepared to testify before Congress , under oath, that their corporation is not involved in biological warfare programs?

    ===============================
    Martin, Joseph Joseph B. Martin, M.D., Ph.D., has served as a Director of Baxter since 2002. Dr. Martin serves as Professor of Neurobiology at Harvard Medical School. From July 1997 to July 2007, Dr. Martin served as Dean of the Harvard Faculty of Medicine. He was Chancellor of the University of California, San Francisco from 1993 to 1997 and Dean of the UCSF School of Medicine from 1989 to 1993. From 1978 to 1989, he was chief of the neurology department of Massachusetts General Hospital and Professor of Neurology at Harvard Medical School. Dr. Martin also serves as a director of Scientific Learning Corp.

    Joseph B Martin
    221 N Walnut St
    Bensenville, IL 60106
    Phone Unpublished

    Joseph B Martin
    2412 N 76th Ave
    Elmwood Park, IL 60707
    (708) 452-7829

    Baxter’s explanation so far has been chilling to put it mildly. Furthermore, it would be in Baxter’s best interest, if it were not involved in criminal activities, to set the record straight? Does Baxter not agree its silence and weak explanations suggest possible criminal malfeasance? If not criminally involved, why will Baxter executives not provide a complete and full account of this supposed contamination, (if indeed it was contamination rather than intentional weaponization.)

    ===============================
    McGillivray, Bruce Mr. Bruce H. McGillivray is Baxter International Inc.’s Corporate Vice President — President, Renal, having served in that capacity since August 2004. From 2002 until August 2004, Mr. McGillivray was President of Renal, Europe and from 1997 to 2002, he was
    President of Baxter Corporation in Canada.

    Bruce H Mcgillivray
    151 Ridge Ln
    Lake Forest, IL 60045
    (847) 283-0021

    Do Baxter executives have any financial and/or personal connections to Toyama Pharma and T-705, an influenza polymerase inhibitor? Has Baxter experimented with influenza polymerase inhibitors? Will Baxter disclose precisely what its financial positions are regarding H5N1 pandemic ‘therapy’ included its intended market timelines? The ‘contamination’ was an extremely serious breach of risk as Baxter could have easily exterminated most of the human race if this experimental material was made into vaccines.

    ===============================
    Parkinson, Robert Mr. Robert L. Parkinson, Jr., is Chairman and Chief Executive Officer of Baxter International Inc., having served in that capacity since April 2004. Prior to joining Baxter, Mr. Parkinson was Dean of Loyola University Chicago’s School of Business Administration and Graduate School of Business from 2002 to 2004. He retired from Abbott Laboratories in 2001 following a 25-year career, having served in a variety of domestic and international management and leadership positions, including as President and Chief Operating Officer. Mr. Parkinson also serves on the boards of directors of Chicago-based Northwestern Memorial Hospital and the Northwestern Memorial Foundation as well as Loyola University Chicago’s Board of Trustees.

    Robert Parkinson
    2525 Waukegan Rd
    Deerfield, IL 60015
    (847) 444-1449

    Why does Baxter hold patents on avian influenza RNA polymerase promoters? What legitimate public health and/or scientific interest does Baxter have in this research? (see Application number: 10/547,155, Publication number: US 2007/0134270 A) Will all Baxter executives come forward and immediately renounce weaponization of biologics? Are Baxter executives concerned about possible civil and/or criminal actions brought against them? Why or why not?

    ===============================
    Riedel, Norbert Mr. Norbert G. Riedel is Corporate Vice President and Chief Scientific Officer of Baxter International Inc., having served in that capacity since May 2001. From 1998 to 2001, he served as President of the recombinant business unit of BioScience. Prior to joining Baxter, Dr. Riedel was head of worldwide biotechnology and worldwide core research functions at Hoechst Marion Roussel, now Sanofi-Aventis.

    Norbert G Riedel
    1520 N Sheridan Rd
    Lake Forest, IL 60045
    (847) 735-1242

    What are the financial connections between the Federal Reserve System and Baxter? Does Baxter receive funding from JP Morgan or Goldman Sachs? Does Baxter receive any national security exemptions (waivers)?

    ===============================
    Terrell, Karenann Ms. Karenann K. Terrell is Corporate Vice President and Chief Information Officer of Baxter International Inc. Prior to joining Baxter in April 2006, Ms. Terrell was with DaimlerChrysler Corporation from 2000 where she served in various positions, the most recent of which was Vice President and Chief Information Officer, Chrysler Group and Mercedes Benz North America. Prior to that, she spent 16 years with General Motors with responsibility for brand development and e-business management.

    Karenann K Terrell
    914 Queens Ln
    Glenview, IL 60025
    Phone Unpublished

    What specific steps , including a precise timeline, does Baxter plan on doing to allay the concerns of both the public and the scientific community? Again, can Baxter please describe the presice nature of their H5N1 strain, including genetic sequences, from where it was obtained, and whether it was genetically engineered? If genetically engineered, what modifications were made? Single nucleotide polymorphisms? RNA Recombination? Reassortment? What exactly, was in this experimental vaccine material? We want scientific answers immediately.

    ===============================
    White, Cheryl Ms. Cheryl L. White is Corporate Vice President, Quality of Baxter International Inc., having served in that capacity since March 2006. From 1997 to 2006, Ms. White held various management positions in Baxter’s BioScience business, the most recent of which was Vice President, Quality Management.

    Cheryl L White
    481 S Commons Ct
    Deerfield, IL 60015
    Phone Unpublished

  2. Innocent Address said, on June 11, 2009 at 11:38 pm

    All,

    I have no comment for or against your cause, but as just a regular citizen – completely unassociated with Baxter – I just want to point out that the addresses in this comment are not all correct.

    I now live at one of the listed addresses – not the Baxter Exec as stated.

    I wish my address wasn’t associated with this! If possible, can it be removed?

    Thanks.

  3. maasanova said, on June 12, 2009 at 12:34 am

    Which address is it and I’ll edit it. You can e-mail me at imaginaryfriend2202@yahoo.com if you want.


Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: